Jul 01, 2026
14 MIN READ

Is Wegovy Injected? Understanding the Administration of This Weight Loss Medication

Wegovy is administered as a once-weekly subcutaneous injection that delivers semaglutide directly under the skin. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, making this proven weight loss therapy accessible without insurance.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jul 01, 2026
14 MIN READ

is wegovy injected? understanding the administration of this weight loss medicat — PlexusDx GLP-1 education

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy operates as a once-weekly injectable medication containing semaglutide, a GLP-1 receptor agonist that reduces appetite and blood sugar levels. The injection method allows for consistent medication delivery and predictable weekly dosing schedules. PlexusDx provides access to compounded semaglutide injections for patients seeking effective weight management without the complexity of insurance requirements.

How Semaglutide Injections Deliver Weight Loss Results

Semaglutide injections work by mimicking glucagon-like peptide-1, a hormone that regulates hunger and blood sugar. When injected subcutaneously once weekly, the medication reaches peak effectiveness within 1–3 days and remains active throughout the seven-day cycle. Clinical trials show patients using semaglutide achieve 15–22% body weight reduction over 68 weeks, significantly outperforming diet and exercise alone.

The injection format allows the medication to enter the bloodstream gradually, creating stable drug levels that suppress appetite without the peaks and valleys of oral formulations. This steady-state delivery reduces nausea and gastrointestinal side effects compared to some alternative routes. PlexusDx compounded semaglutide injections maintain the same pharmacological profile as brand-name versions, originating from licensed 503A compounding pharmacies that meet rigorous FDA standards.

Injection Technique and Administration at Home

Semaglutide injections are administered subcutaneously into the abdomen, thigh, or upper arm—areas with adequate fatty tissue for absorption. Patients self-inject once weekly using a pre-filled pen device, a procedure taking less than one minute and requiring minimal training. The needle gauge is small (typically 31G), making the injection minimally uncomfortable for most patients.

PlexusDx patients receive detailed instruction materials and video guidance for proper injection technique, site rotation, and storage requirements. Refrigeration is required until the first use, after which the pen can remain at room temperature for 30 days. Many patients report that the simplicity of weekly dosing improves medication adherence compared to daily oral alternatives.

Compounded vs. Brand-Name Semaglutide Injections

PlexusDx compounded semaglutide injections are manufactured by licensed 503A compounding pharmacies, which are regulated by state pharmacy boards and the FDA. While not FDA-approved as finished products, 503A compounded medications contain the same active pharmaceutical ingredient as brand-name Wegovy and are produced under stringent quality controls. Cost savings of 20–50% compared to brand names reflect reduced marketing expenses, not reduced efficacy or safety.

Patients choosing PlexusDx compounded semaglutide injections starting at $149/month gain access without insurance coverage, membership fees, or prior authorization delays. HSA and FSA accounts are accepted, expanding payment flexibility. The Precision Peptide Genetic Test can identify individual variations in GLP-1 receptor sensitivity (GLP1R rs6923761), helping optimize dosing strategy for maximum results.

Dosing Schedule and Titration Protocol

Semaglutide injection therapy begins with a 0.25 mg starting dose to allow patients to acclimate and assess individual tolerability. Doses increase every four weeks by 0.25 mg increments, with most patients reaching therapeutic benefit at 1.0–2.4 mg weekly. The gradual titration approach reduces nausea and gastrointestinal adaptation, improving long-term medication tolerance.

PlexusDx pricing remains flat regardless of dose level—your dose may need to go up, but your price won't. Monthly compounded semaglutide injection packages are customized to each patient's current dose, ensuring patients pay only for the strength they require. Treatment can continue indefinitely at maintenance doses, with many patients sustaining weight loss through ongoing therapy.

When to Choose Injection vs. Oral Semaglutide

Injectable semaglutide offers superior bioavailability and more consistent blood levels compared to oral tablets, which require fasting and careful timing. Patients with swallowing difficulties, gastrointestinal disorders, or those who prefer convenience typically benefit from the injection route. Clinical data shows injection formulations produce slightly faster weight loss and lower dropout rates due to fewer GI side effects.

PlexusDx offers both compounded semaglutide injection (starting at $149/month) and oral semaglutide (starting at $249/month), allowing patients to choose based on preference and clinical response. Some patients begin with injections for faster results, then transition to oral maintenance if preferred. The Precision Peptide Genetic Test helps predict individual tolerability patterns across different administration routes.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Wegovy always injected, or are there other ways to take it?

Wegovy brand-name is exclusively injectable. However, semaglutide comes in both injection and oral tablet forms from other manufacturers. PlexusDx provides both compounded semaglutide injection ($149/mo) and oral semaglutide ($249/mo), so patients can select their preferred administration method based on lifestyle and tolerance.

How painful is a semaglutide injection, and where do you inject it?

Semaglutide injections use a very small 31-gauge needle, similar in discomfort to a blood glucose test. Injections are placed subcutaneously in the abdomen, thigh, or upper arm—areas with adequate fat tissue. Most patients report minimal pain after the first few injections once technique and anxiety decrease.

Can PlexusDx compounded semaglutide injections be covered by insurance?

PlexusDx does not require insurance and charges a flat monthly rate starting at $149 for semaglutide injection. However, HSA and FSA accounts are eligible for reimbursement. Patients should confirm their account plan's terms, as most high-deductible health plans recognize semaglutide injections as qualified medical expenses.

What are the main side effects of semaglutide injections?

Common side effects include mild nausea, vomiting, constipation, and reduced appetite during the first 2–4 weeks. Most patients experience symptom resolution within 4–6 weeks as the body adapts. Rare but serious risks include pancreatitis and gallbladder issues; patients with personal or family history of medullary thyroid cancer should avoid GLP-1 medications.

Does PlexusDx offer genetic testing to predict how I'll respond to semaglutide injections?

Yes—the PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) analyzes 14 pathways including the GLP1R rs6923761 variant, which influences receptor sensitivity to semaglutide. This insight helps predict optimal dosing strategy and likelihood of side effect tolerance, allowing for truly personalized weight loss therapy.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves